CONMED Total Non-Cash Items 2010-2025 | CNMD

CONMED total non-cash items from 2010 to 2025. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
CONMED Annual Total Non-Cash Items
(Millions of US $)
2024 $74
2023 $100
2022 $205
2021 $105
2020 $85
2019 $90
2018 $78
2017 $27
2016 $59
2015 $54
2014 $55
2013 $61
2012 $65
2011 $95
2010 $59
2009 $48
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.865B $1.307B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.604B 21.88
Becton Dickinson (BDX) United States $50.274B 12.45
Cardinal Health (CAH) United States $36.816B 19.28
Straumann Holding AG (SAUHY) Switzerland $21.909B 0.00
Labcorp (LH) United States $20.885B 16.94
Cooper (COO) United States $16.582B 22.00
West Pharmaceutical Services (WST) United States $15.565B 32.63
Align Technology (ALGN) United States $13.648B 27.09
Henry Schein (HSIC) United States $8.770B 15.04
Merit Medical Systems (MMSI) United States $5.841B 28.24
DENTSPLY SIRONA (XRAY) United States $3.328B 9.94
STAAR Surgical (STAA) United States $0.952B 0.00
Lifevantage (LFVN) United States $0.169B 17.39
Pro-Dex (PDEX) United States $0.141B 15.40